{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T13:59:19Z","timestamp":1792677559589,"version":"4.5.0"},"reference-count":105,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23HL166961"],"award-info":[{"award-number":["K23HL166961"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiology Clinics"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.ccl.2024.02.005","type":"journal-article","created":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T04:09:41Z","timestamp":1710475781000},"page":"165-186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Acute Heart Failure"],"prefix":"10.1016","volume":"42","author":[{"given":"Megan","family":"Sheehan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Sokoloff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nosheen","family":"Reza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ccl.2024.02.005_bib1","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s40273-020-00952-0","article-title":"A\u00a0systematic review of medical Costs associated with heart failure in the USA (2014\u20132020)","volume":"38","author":"Urbich","year":"2020","journal-title":"Pharmacoeconomics"},{"issue":"12","key":"10.1016\/j.ccl.2024.02.005_bib2","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1007\/s11886-022-01822-1","article-title":"Contemporary data on the status and medical management of acute heart failure","volume":"24","author":"Bazmpani","year":"2022","journal-title":"Curr Cardiol Rep"},{"issue":"4","key":"10.1016\/j.ccl.2024.02.005_bib3","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00134-010-2113-0","article-title":"Clinical presentation, management and outcomes in the acute heart failure Global Survey of standard treatment (ALARM-HF)","volume":"37","author":"Follath","year":"2011","journal-title":"Intensive Care Med"},{"issue":"3","key":"10.1016\/j.ccl.2024.02.005_bib4","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jchf.2023.02.001","article-title":"Proposed new Conceptualization for definition of decompensated HF: Taking the acute out of decompensation","volume":"11","author":"Bozkurt","year":"2023","journal-title":"JACC Heart Fail"},{"issue":"36","key":"10.1016\/j.ccl.2024.02.005_bib5","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.ccl.2024.02.005_bib6","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1007\/s11897-022-00576-9","article-title":"\u2018Acute heart failure\u2019: should We Abandon the term Altogether?","volume":"19","author":"Straw","year":"2022","journal-title":"Curr Heart Fail Rep"},{"issue":"2","key":"10.1016\/j.ccl.2024.02.005_bib7","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ahj.2004.08.005","article-title":"Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)","volume":"149","author":"Adams","year":"2005","journal-title":"Am Heart J"},{"issue":"8","key":"10.1016\/j.ccl.2024.02.005_bib8","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.jacc.2007.04.064","article-title":"Characteristics, treatments, and outcomes of patients with preserved systolic function hospitalized for heart failure: a report from the OPTIMIZE-HF registry","volume":"50","author":"Fonarow","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.ccl.2024.02.005_bib9","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jacc.2008.04.028","article-title":"Predictors of in-hospital mortality in patients hospitalized for heart failure: insights from the Organized program to initiate Lifesaving treatment in hospitalized patients with heart failure (OPTIMIZE-HF)","volume":"52","author":"Abraham","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.ccl.2024.02.005_bib10","doi-asserted-by":"crossref","first-page":"e475","DOI":"10.1097\/MJT.0000000000000791","article-title":"Improving post-discharge outcomes in acute heart failure","volume":"25","author":"Chioncel","year":"2018","journal-title":"Am J Ther"},{"issue":"4","key":"10.1016\/j.ccl.2024.02.005_bib11","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/ejhf.471","article-title":"The real-world evidence of heart failure: findings from 41 413 patients of the ARNO database","volume":"18","author":"Maggioni","year":"2016","journal-title":"Eur J Heart Fail"},{"issue":"18","key":"10.1016\/j.ccl.2024.02.005_bib12","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American heart association Joint Committee on clinical practice guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ccl.2024.02.005_bib13","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/ejhf.682","article-title":"Precipitating factors and 90-day outcome of acute heart failure: a report from the intercontinental GREAT registry","volume":"19","author":"Arrigo","year":"2017","journal-title":"Eur J Heart Fail"},{"issue":"19","key":"10.1016\/j.ccl.2024.02.005_bib14","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1001\/archinte.161.19.2337","article-title":"Acute precipitants of congestive heart failure Exacerbations","volume":"161","author":"Tsuyuki","year":"2001","journal-title":"Arch Intern Med"},{"issue":"8","key":"10.1016\/j.ccl.2024.02.005_bib15","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/archinte.168.8.847","article-title":"Factors identified as precipitating hospital admissions for heart failure and clinical outcomes: findings from OPTIMIZE-HF","volume":"168","author":"Fonarow","year":"2008","journal-title":"Arch Intern Med"},{"issue":"3","key":"10.1016\/j.ccl.2024.02.005_bib16","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jchf.2014.01.006","article-title":"The burden of acute heart failure on U.S. emergency departments","volume":"2","author":"Storrow","year":"2014","journal-title":"JACC Heart Fail"},{"issue":"3","key":"10.1016\/j.ccl.2024.02.005_bib17","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/acem.12878","article-title":"Diagnosing acute heart failure in the emergency department: a systematic review and meta-analysis","volume":"23","author":"Martindale","year":"2016","journal-title":"Acad Emerg Med"},{"issue":"1","key":"10.1016\/j.ccl.2024.02.005_bib18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.annemergmed.2005.04.003","article-title":"Prevalence of Negative chest Radiography results in the emergency department patient with decompensated heart failure","volume":"47","author":"Collins","year":"2006","journal-title":"Ann Emerg Med"},{"issue":"8","key":"10.1016\/j.ccl.2024.02.005_bib19","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.ajem.2013.05.007","article-title":"Diagnosing heart failure among acutely dyspneic patients with cardiac, inferior vena cava, and lung ultrasonography","volume":"31","author":"Anderson","year":"2013","journal-title":"Am J Emerg Med"},{"issue":"19","key":"10.1016\/j.ccl.2024.02.005_bib20","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1161\/CIR.0b013e3181f9a223","article-title":"Acute heart failure syndromes: emergency department presentation, treatment, and disposition: current approaches and future aims: a scientific statement from the American Heart Association","volume":"122","author":"Weintraub","year":"2010","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ccl.2024.02.005_bib21","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1016\/j.ijcard.2013.01.228","article-title":"Incremental value of biomarkers to clinical variables for mortality prediction in acutely decompensated heart failure: the Multinational Observational Cohort on Acute Heart Failure (MOCA) study","volume":"168","author":"Lassus","year":"2013","journal-title":"Int J Cardiol"},{"issue":"4","key":"10.1016\/j.ccl.2024.02.005_bib22","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ahj.2004.07.010","article-title":"Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy","volume":"149","author":"Krauser","year":"2005","journal-title":"Am Heart J"},{"issue":"1","key":"10.1016\/j.ccl.2024.02.005_bib23","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jacc.2005.08.051","article-title":"Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study","volume":"47","author":"Anwaruddin","year":"2006","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"24","key":"10.1016\/j.ccl.2024.02.005_bib24","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1001\/jama.294.24.3124","article-title":"Noninvasive ventilation in acute cardiogenic pulmonary edema: systematic review and meta-analysis","volume":"294","author":"Masip","year":"2005","journal-title":"JAMA"},{"issue":"25","key":"10.1016\/j.ccl.2024.02.005_bib25","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1016\/j.jacc.2017.04.042","article-title":"Time-to-Furosemide treatment and mortality in patients hospitalized with acute heart failure","volume":"69","author":"Matsue","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"6","key":"10.1016\/j.ccl.2024.02.005_bib26","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1751-7133.2009.00112.x","article-title":"Early vasoactive drugs improve heart failure outcomes","volume":"15","author":"Peacock","year":"2009","journal-title":"Congest Heart Fail Greenwich Conn"},{"issue":"10","key":"10.1016\/j.ccl.2024.02.005_bib28","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.cardfail.2022.05.006","article-title":"Current emergency department disposition of patients with acute heart failure: an opportunity for improvement","volume":"28","author":"Sax","year":"2022","journal-title":"J\u00a0Card Fail"},{"issue":"5","key":"10.1016\/j.ccl.2024.02.005_bib29","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/2048872620930889","article-title":"Risk stratification scores for patients with acute heart failure in the Emergency Department: a systematic review","volume":"9","author":"Mir\u00f3","year":"2020","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"issue":"4","key":"10.1016\/j.ccl.2024.02.005_bib30","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1067\/mhj.2001.118473","article-title":"Outcomes after emergency department discharge with a primary diagnosis of heart failure","volume":"142","author":"Rame","year":"2001","journal-title":"Am Heart J"},{"issue":"3","key":"10.1016\/j.ccl.2024.02.005_bib31","article-title":"Outcomes of heart failure admissions under observation versus short inpatient stay","volume":"7","author":"Masri","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"15","key":"10.1016\/j.ccl.2024.02.005_bib32","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1016\/j.jacc.2019.08.001","article-title":"2019 ACC expert consensus decision Pathway on risk assessment, management, and clinical trajectory of patients hospitalized with heart failure: a report of the American College of Cardiology Solution set Oversight Committee","volume":"74","author":"Hollenberg","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ccl.2024.02.005_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-020-0151-7","article-title":"Acute heart failure","volume":"6","author":"Arrigo","year":"2020","journal-title":"Nat Rev Dis Primer"},{"issue":"10","key":"10.1016\/j.ccl.2024.02.005_bib34","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.jacc.2019.12.059","article-title":"Diuretic therapy for patients with heart failure: JACC State-of-the-Art review","volume":"75","author":"Felker","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"13","key":"10.1016\/j.ccl.2024.02.005_bib35","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1056\/NEJMoa2203094","article-title":"Acetazolamide in acute decompensated heart failure with volume overload","volume":"387","author":"Mullens","year":"2022","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.ccl.2024.02.005_bib36","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1056\/NEJMoa1005419","article-title":"Diuretic strategies in patients with acute decompensated heart failure","volume":"364","author":"Felker","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2024.02.005_bib37","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ijcard.2018.01.067","article-title":"Prevalence, predictors and clinical outcome of residual congestion in acute decompensated heart failure","volume":"258","author":"Rubio-Gracia","year":"2018","journal-title":"Int J Cardiol"},{"issue":"12","key":"10.1016\/j.ccl.2024.02.005_bib38","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1093\/eurjhf\/hft110","article-title":"Haemoconcentration, renal function, and post-discharge outcomes among patients hospitalized for heart failure with reduced ejection fraction: insights from the EVEREST trial","volume":"15","author":"Greene","year":"2013","journal-title":"Eur J Heart Fail"},{"issue":"13","key":"10.1016\/j.ccl.2024.02.005_bib39","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1001\/jama.294.13.1625","article-title":"Evaluation study of congestive heart failure and pulmonary artery catheterization effectiveness: the ESCAPE trial","volume":"294","author":"Binanay","year":"2005","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ccl.2024.02.005_bib41","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.122.010206","article-title":"In-hospital observation on oral diuretics after treatment for acute decompensated heart failure: Evaluating the utility","volume":"16","author":"Ivey-Miranda","year":"2023","journal-title":"Circ Heart Fail"},{"issue":"3","key":"10.1016\/j.ccl.2024.02.005_bib42","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jacc.2008.03.048","article-title":"Influence of beta-blocker continuation or withdrawal on outcomes in patients hospitalized with heart failure: findings from the OPTIMIZE-HF program","volume":"52","author":"Fonarow","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"2","key":"10.1016\/j.ccl.2024.02.005_bib43","article-title":"Initiation, continuation, or withdrawal of angiotensin-converting enzyme inhibitors\/angiotensin receptor blockers and outcomes in patients hospitalized with heart failure with reduced ejection fraction","volume":"6","author":"Gilstrap","year":"2017","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"5","key":"10.1016\/j.ccl.2024.02.005_bib44","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.amjcard.2014.05.062","article-title":"Effect of spironolactone on 30-day death and heart failure rehospitalization (from the COACH study)","volume":"114","author":"Maisel","year":"2014","journal-title":"Am J Cardiol"},{"issue":"19","key":"10.1016\/j.ccl.2024.02.005_bib45","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1161\/CIRCULATIONAHA.117.030112","article-title":"Worsening renal function in patients with acute heart failure undergoing Aggressive diuresis is not associated with tubular injury","volume":"137","author":"Ahmad","year":"2018","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.ccl.2024.02.005_bib46","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.amjmed.2014.11.036","article-title":"Beta-Blocker Use and 30-day all-cause readmission in Medicare Beneficiaries with systolic heart failure","volume":"128","author":"Bhatia","year":"2015","journal-title":"Am J Med"},{"issue":"2","key":"10.1016\/j.ccl.2024.02.005_bib47","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa2030183","article-title":"Sotagliflozin in patients with diabetes and recent worsening heart failure","volume":"384","author":"Bhatt","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ccl.2024.02.005_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.cardfail.2023.03.025","article-title":"Iron deficiency in heart failure: a scientific statement from the heart failure society of America","author":"Beavers","year":"2023","journal-title":"J\u00a0Card Fail"},{"issue":"4","key":"10.1016\/j.ccl.2024.02.005_bib49","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ahj.2013.01.017","article-title":"Iron deficiency in chronic heart failure: an international pooled analysis","volume":"165","author":"Klip","year":"2013","journal-title":"Am Heart J"},{"issue":"10266","key":"10.1016\/j.ccl.2024.02.005_bib50","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/S0140-6736(20)32339-4","article-title":"Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial","volume":"396","author":"Ponikowski","year":"2020","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.ccl.2024.02.005_bib51","doi-asserted-by":"crossref","DOI":"10.1136\/heartjnl-2022-321097","article-title":"Management of patients with heart failure and preserved ejection fraction","author":"Jasinska-Piadlo","year":"2023","journal-title":"Heart"},{"issue":"16","key":"10.1016\/j.ccl.2024.02.005_bib52","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.ccl.2024.02.005_bib53","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/s41591-021-01659-1","article-title":"The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial","volume":"28","author":"Voors","year":"2022","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.ccl.2024.02.005_bib54","doi-asserted-by":"crossref","first-page":"902","DOI":"10.4330\/wjc.v7.i12.902","article-title":"Predicting mortality in patients with acute heart failure: Role of risk scores","volume":"7","author":"Passantino","year":"2015","journal-title":"World J Cardiol"},{"issue":"5","key":"10.1016\/j.ccl.2024.02.005_bib55","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1001\/jama.293.5.572","article-title":"ADHERE Scientific Advisory Committee, Study Group, and Investigators. Risk stratification for in-hospital mortality in acutely decompensated heart failure: classification and regression tree analysis","volume":"293","author":"Fonarow","year":"2005","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.ccl.2024.02.005_bib56","first-page":"115","article-title":"A\u00a0novel discharge risk model for patients hospitalised for acute decompensated heart failure incorporating N-terminal pro-B-type natriuretic peptide levels: a European coLlaboration on Acute decompeNsated Heart Failure: ELAN-HF Score","volume":"100","author":"Salah","year":"2014","journal-title":"Heart Br Card Soc"},{"issue":"3","key":"10.1016\/j.ccl.2024.02.005_bib57","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1016\/j.ijcard.2013.01.005","article-title":"Clinical utility of N-terminal pro-B-type natriuretic peptide for risk stratification of patients with acute decompensated heart failure. Derivation and validation of the ADHF\/NT-proBNP risk score","volume":"168","author":"Scrutinio","year":"2013","journal-title":"Int J Cardiol"},{"issue":"1","key":"10.1016\/j.ccl.2024.02.005_bib58","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1161\/CIRCULATIONAHA.117.027551","article-title":"Trends in hospitalizations and survival of acute decompensated heart failure in four US Communities (2005-2014): ARIC study Community Surveillance","volume":"138","author":"Chang","year":"2018","journal-title":"Circulation"},{"issue":"Suppl 1","key":"10.1016\/j.ccl.2024.02.005_bib59","first-page":"S40","article-title":"Evolving therapeutic strategies for patients hospitalized with new or worsening heart failure across the spectrum of left ventricular ejection fraction","volume":"45","author":"Ostrominski","year":"2022","journal-title":"Clin Cardiol"},{"issue":"11","key":"10.1016\/j.ccl.2024.02.005_bib60","doi-asserted-by":"crossref","first-page":"774","DOI":"10.7326\/M14-0083","article-title":"Transitional care interventions to prevent readmissions for persons with heart failure: a systematic review and meta-analysis","volume":"160","author":"Feltner","year":"2014","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.ccl.2024.02.005_bib61","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa2026141","article-title":"Physical rehabilitation for older patients hospitalized for heart failure","volume":"385","author":"Kitzman","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.ccl.2024.02.005_bib62","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1136\/heartjnl-2019-315568","article-title":"Assessment and management of cardiovascular disease in the intensive care unit","volume":"108","author":"Cook","year":"2022","journal-title":"Heart"},{"issue":"1","key":"10.1016\/j.ccl.2024.02.005_bib63","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/ccd.28329","article-title":"SCAI clinical expert consensus statement on the classification of cardiogenic shock","volume":"94","author":"Baran","year":"2019","journal-title":"Catheter Cardiovasc Interv"},{"issue":"5","key":"10.1016\/j.ccl.2024.02.005_bib64","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/ejhf.260","article-title":"Clinical picture and risk prediction of short-term mortality in cardiogenic shock","volume":"17","author":"Harjola","year":"2015","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"10.1016\/j.ccl.2024.02.005_bib65","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.cardfail.2019.03.004","article-title":"Trends in utilization and outcomes of pulmonary artery catheterization in heart failure with and without cardiogenic shock","volume":"25","author":"Hernandez","year":"2019","journal-title":"J\u00a0Card Fail"},{"issue":"13","key":"10.1016\/j.ccl.2024.02.005_bib66","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.jacc.2018.06.074","article-title":"Positive pressure ventilation in the cardiac intensive care Unit","volume":"72","author":"Alviar","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.ccl.2024.02.005_bib67","first-page":"CD005351","article-title":"Non-invasive positive pressure ventilation (CPAP or bilevel NPPV) for cardiogenic pulmonary oedema","volume":"4","author":"Berbenetz","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"10.1016\/j.ccl.2024.02.005_bib68","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1056\/NEJMoa2026845","article-title":"Milrinone as compared with dobutamine in the treatment of cardiogenic shock","volume":"385","author":"Mathew","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.ccl.2024.02.005_bib69","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jacc.2018.04.051","article-title":"Epinephrine versus norepinephrine for cardiogenic shock after acute myocardial infarction","volume":"72","author":"Levy","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ccl.2024.02.005_bib70","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/CCM.0b013e3181ffe0eb","article-title":"Comparison of norepinephrine-dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock. A prospective, randomized pilot study","volume":"39","author":"Levy","year":"2011","journal-title":"Crit Care Med"},{"issue":"9","key":"10.1016\/j.ccl.2024.02.005_bib71","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1056\/NEJMoa0907118","article-title":"Comparison of dopamine and norepinephrine in the treatment of shock","volume":"362","author":"De Backer","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"14","key":"10.1016\/j.ccl.2024.02.005_bib72","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1016\/j.jacc.2014.07.958","article-title":"National trends in the utilization of short-term mechanical circulatory support: incidence, outcomes, and cost analysis","volume":"64","author":"Stretch","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"5","key":"10.1016\/j.ccl.2024.02.005_bib73","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.007924","article-title":"Clinical outcomes associated with acute mechanical circulatory support utilization in heart failure related cardiogenic shock","volume":"14","author":"Hernandez-Montfort","year":"2021","journal-title":"Circ Heart Fail"},{"issue":"14","key":"10.1016\/j.ccl.2024.02.005_bib74","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1208410","article-title":"Intraaortic balloon support for myocardial infarction with cardiogenic shock","volume":"367","author":"Thiele","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.ccl.2024.02.005_bib75","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.cardfail.2021.08.010","article-title":"Heart failure-related cardiogenic shock: Pathophysiology, evaluation and management considerations: review of heart failure-related cardiogenic shock","volume":"27","author":"Abraham","year":"2021","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.ccl.2024.02.005_bib76","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ahj.2020.11.017","article-title":"Early intra-aortic balloon pump in acute decompensated heart failure complicated by cardiogenic shock: rationale and design of the randomized Altshock-2 trial","volume":"233","author":"Morici","year":"2021","journal-title":"Am Heart J"},{"issue":"10","key":"10.1016\/j.ccl.2024.02.005_bib77","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1161\/CIRCULATIONAHA.118.036614","article-title":"Impella support for acute myocardial infarction complicated by cardiogenic shock","volume":"139","author":"Schrage","year":"2019","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.ccl.2024.02.005_bib78","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.healun.2019.11.009","article-title":"Longitudinal impact of temporary mechanical circulatory support on durable ventricular assist device outcomes: an IMACS registry propensity matched analysis","volume":"39","author":"Hernandez-Montfort","year":"2020","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"1","key":"10.1016\/j.ccl.2024.02.005_bib79","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/ejcts\/ezx088","article-title":"Short-term mechanical circulatory support as a bridge to durable left ventricular assist device implantation in refractory cardiogenic shock: a systematic review and meta-analysis","volume":"52","author":"den Uil","year":"2017","journal-title":"Eur J Cardio Thorac Surg"},{"issue":"4","key":"10.1016\/j.ccl.2024.02.005_bib80","article-title":"In-hospital worsening heart failure and associations with mortality, readmission, and healthcare utilization","volume":"3","author":"DeVore","year":"2014","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"9","key":"10.1016\/j.ccl.2024.02.005_bib81","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.007099","article-title":"Invasive hemodynamic assessment and classification of in-hospital mortality risk among patients with cardiogenic shock","volume":"13","author":"Thayer","year":"2020","journal-title":"Circ Heart Fail"},{"issue":"5","key":"10.1016\/j.ccl.2024.02.005_bib82","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.amjcard.2014.12.023","article-title":"Palliative care in the cardiac intensive care Unit","volume":"115","author":"Naib","year":"2015","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.ccl.2024.02.005_bib83","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1089\/jpm.2014.0192","article-title":"Inpatient palliative care for patients with acute heart failure: outcomes from a randomized trial","volume":"18","author":"Sidebottom","year":"2015","journal-title":"J\u00a0Palliat Med"},{"issue":"4","key":"10.1016\/j.ccl.2024.02.005_bib84","doi-asserted-by":"crossref","first-page":"248","DOI":"10.7326\/M18-1967","article-title":"External validation of the MEESSI acute heart failure risk score: a cohort study","volume":"170","author":"Wussler","year":"2019","journal-title":"Ann Intern Med"},{"issue":"11","key":"10.1016\/j.ccl.2024.02.005_bib85","doi-asserted-by":"crossref","first-page":"767","DOI":"10.7326\/0003-4819-156-11-201206050-00003","article-title":"Prediction of heart failure mortality in emergent care: a cohort study","volume":"156","author":"Lee","year":"2012","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.ccl.2024.02.005_bib86","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/acem.13141","article-title":"Prospective and Explicit clinical validation of the Ottawa heart failure risk scale, with and without Use of Quantitative NT-proBNP","volume":"24","author":"Stiell","year":"2017","journal-title":"Acad Emerg Med"},{"issue":"10","key":"10.1016\/j.ccl.2024.02.005_bib87","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jchf.2015.05.007","article-title":"Identification of emergency department patients with acute heart failure at low risk for 30-day adverse events: the STRATIFY decision tool","volume":"3","author":"Collins","year":"2015","journal-title":"JACC Heart Fail"},{"issue":"3","key":"10.1016\/j.ccl.2024.02.005_bib88","article-title":"Risk adjusted 30-day mortality and serious adverse event rates among a large, multi-center cohort of emergency department patients with acute heart failure","volume":"3","author":"Sax","year":"2022","journal-title":"J\u00a0Am Coll Emerg Physicians Open"},{"issue":"1","key":"10.1016\/j.ccl.2024.02.005_bib89","first-page":"76","article-title":"Association of mineralocorticoid receptor antagonist use and in-hospital outcomes in patients with acute heart failure","volume":"107","author":"Bistola","year":"2018","journal-title":"Clin Res Cardiol Off J Ger Card Soc"},{"issue":"6","key":"10.1016\/j.ccl.2024.02.005_bib90","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.5892","article-title":"Association of mineralocorticoid receptor antagonist Use with all-cause mortality and hospital readmission in older Adults with acute decompensated heart failure","volume":"2","author":"Yaku","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"12","key":"10.1016\/j.ccl.2024.02.005_bib91","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.jchf.2021.06.018","article-title":"Sacubitril\/Valsartan adherence and Postdischarge outcomes among patients hospitalized for heart failure with reduced ejection fraction","volume":"9","author":"Carnicelli","year":"2021","journal-title":"JACC Heart Fail"},{"issue":"3","key":"10.1016\/j.ccl.2024.02.005_bib92","first-page":"505","article-title":"Impact of Canagliflozin in patients with type 2 diabetes after hospitalization for acute heart failure: a cohort study","volume":"10","author":"Mart\u00edn","year":"2021","journal-title":"J\u00a0Clin Med"},{"issue":"3","key":"10.1016\/j.ccl.2024.02.005_bib93","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/jgs.17585","article-title":"Clinical benefits of empagliflozin in very old patients with type 2 diabetes hospitalized for acute heart failure","volume":"70","author":"P\u00e9rez-Belmonte","year":"2022","journal-title":"J\u00a0Am Geriatr Soc"},{"issue":"9","key":"10.1016\/j.ccl.2024.02.005_bib94","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.jacc.2003.12.040","volume":"43","author":"Gattis","year":"2004","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.ccl.2024.02.005_bib95","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ejim.2013.08.711","article-title":"Mineralocorticoid receptor antagonism in acutely decompensated chronic heart failure","volume":"25","author":"Ferreira","year":"2014","journal-title":"Eur J Intern Med"},{"issue":"9","key":"10.1016\/j.ccl.2024.02.005_bib96","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1001\/jamacardio.2017.2198","article-title":"Efficacy and safety of spironolactone in acute heart failure: the ATHENA-HF randomized clinical trial","volume":"2","author":"Butler","year":"2017","journal-title":"JAMA Cardiol"},{"issue":"2","key":"10.1016\/j.ccl.2024.02.005_bib97","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1093\/ehjcvp\/pvaa132","article-title":"Efficacy and safety of early initiation of Eplerenone treatment in patients with acute heart failure (EARLIER trial): a multicentre, randomized, double-blind, placebo-controlled trial","volume":"8","author":"Asakura","year":"2022","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"6","key":"10.1016\/j.ccl.2024.02.005_bib98","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1056\/NEJMoa1812851","article-title":"Angiotensin-neprilysin inhibition in acute decompensated heart failure","volume":"380","author":"Velazquez","year":"2019","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.ccl.2024.02.005_bib99","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/ejhf.1498","article-title":"Initiation of sacubitril\/valsartan in haemodynamically stabilised heart failure patients in hospital or early after discharge: primary results of the randomised TRANSITION study","volume":"21","author":"Wachter","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.ccl.2024.02.005_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2023.04.019","article-title":"Angiotensin-neprilysin inhibition in patients with mildly reduced or preserved ejection fraction and worsening heart failure","author":"Mentz","year":"2023","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.ccl.2024.02.005_bib102","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/ejhf.1713","article-title":"Randomized, double-blind, placebo-controlled, multicentre pilot study on the effects of empagliflozin on clinical outcomes in patients with acute decompensated heart failure (EMPA-RESPONSE-AHF)","volume":"22","author":"Damman","year":"2020","journal-title":"Eur J Heart Fail"},{"issue":"3","key":"10.1016\/j.ccl.2024.02.005_bib103","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.007048","article-title":"Effect of empagliflozin as an Add-on therapy on decongestion and renal function in patients with diabetes hospitalized for acute decompensated heart failure: a prospective randomized controlled study","volume":"14","author":"Tamaki","year":"2021","journal-title":"Circ Heart Fail"},{"issue":"12","key":"10.1016\/j.ccl.2024.02.005_bib104","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"387","author":"Solomon","year":"2022","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.ccl.2024.02.005_bib105","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2021-001936","article-title":"Impact of dapagliflozin treatment on renal function and diuretics use in acute heart failure: a pilot study","volume":"9","author":"Charaya","year":"2022","journal-title":"Open Heart"},{"issue":"4","key":"10.1016\/j.ccl.2024.02.005_bib106","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1161\/CIRCULATIONAHA.122.059038","article-title":"Effects of early empagliflozin initiation on diuresis and kidney function in patients with acute decompensated heart failure (EMPAG-HF)","volume":"146","author":"Schulze","year":"2022","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ccl.2024.02.005_bib107","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1002\/ehf2.13955","article-title":"Empagliflozin reduces markers of acute kidney injury in patients with acute decompensated heart failure","volume":"9","author":"Thiele","year":"2022","journal-title":"ESC Heart Fail"},{"key":"10.1016\/j.ccl.2024.02.005_bib108","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ahj.2020.10.071","article-title":"Efficacy and safety of dapagliflozin in acute heart failure: rationale and design of the DICTATE-AHF trial","volume":"232","author":"Cox","year":"2021","journal-title":"Am Heart J"}],"container-title":["Cardiology Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733865124000158?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733865124000158?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T10:08:02Z","timestamp":1731578882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733865124000158"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":105,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0733865124000158"],"URL":"https:\/\/doi.org\/10.1016\/j.ccl.2024.02.005","relation":{},"ISSN":["0733-8651"],"issn-type":[{"value":"0733-8651","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute Heart Failure","name":"articletitle","label":"Article Title"},{"value":"Cardiology Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccl.2024.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}